Chesnara Plc: Fourth acquisition in two years
12 November 2026
Simulations Plus, Inc. (NASDAQ: SLP), a leader in the healthcare sector, specifically within the health information services industry, offers an intriguing investment opportunity highlighted by a..
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is capturing investor attention with its ambitious goal of transforming the treatment landscape for childhood and adult diseases through innovative..
Evolus, Inc. (NASDAQ: EOLS) stands at a fascinating intersection of opportunity and potential within the healthcare sector. Specializing in the aesthetic market, this Newport Beach-based company..
Trevi Therapeutics, Inc. (NASDAQ: TRVI) stands out in the volatile biotechnology sector, capturing the attention of investors with a staggering potential upside of 170.69%. This clinical-stage..
Investors eyeing opportunities in the cannabis sector should consider the recent performance and future potential of Cronos Group Inc. (NASDAQ: CRON). This Canadian-based company, with a..
Personalis, Inc. (NASDAQ: PSNL) stands at the frontier of the burgeoning cancer genomics sector, offering investors a unique opportunity to tap into a rapidly evolving market...
COMPASS Pathways Plc (NASDAQ: CMPS) is making waves in the healthcare sector, focusing on the burgeoning field of mental health treatment. With a market capitalization of..
Arvinas, Inc. (NASDAQ: ARVN) is making waves in the biotechnology sector with its innovative approach to treating challenging diseases through protein degradation. With a market capitalization..
Gyre Therapeutics, Inc. (NASDAQ: GYRE) is a burgeoning player in the biotechnology industry, focusing on the development and commercialization of drugs targeting organ fibrosis, a condition..
Investors searching for promising opportunities in the biotechnology sector might turn their attention to Tourmaline Bio, Inc. (NASDAQ: TRML), a clinical-stage biotech firm making strides in..
Investors with a keen interest in the biotechnology sector might find Cogent Biosciences, Inc. (NASDAQ: COGT) a compelling prospect. Headquartered in Waltham, Massachusetts, Cogent Biosciences focuses..
Delcath Systems, Inc. (NASDAQ: DCTH) is capturing the attention of investors with its promising potential upside of 111.21%, as indicated by recent analyst ratings. Operating within..
Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its focus on rare respiratory diseases. Headquartered in Langhorne, Pennsylvania,..
In the evolving landscape of biotechnology, Enliven Therapeutics, Inc. (NASDAQ: ELVN), a clinical-stage biopharmaceutical company, is capturing investor attention with its promising pipeline and significant upside..
As investors navigate the ever-evolving landscape of healthcare, Treace Medical Concepts, Inc. (NASDAQ: TMCI) presents a noteworthy opportunity within the medical device sector. With a focus..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, has caught the attention of investors with its promising product pipeline targeting infectious diseases, particularly chronic Hepatitis..
GH Research PLC (NASDAQ: GHRS) is garnering significant attention in the biotech investment community, especially with its potential upside of 128.73% as highlighted by analysts. This..
CeriBell, Inc. (NASDAQ: CBLL), a healthcare company specializing in medical devices, has been gaining attention due to its innovative approach to diagnosing and managing serious neurological..
Altimmune, Inc. (NASDAQ: ALT) is garnering significant attention in the biotechnology sector, where its focus on groundbreaking treatments for obesity, metabolic, and liver diseases positions it..
Fortrea Holdings Inc. (FTRE), a prominent player in the healthcare sector and a provider of biopharmaceutical product development solutions, has caught the attention of investors who..
